2,6-DIAMINOPYRIDINE COMPOUNDS FOR TREATING AMYLOID PROTEIN RELATED PROTEINS AND FOR TREATING OCULAR DISEASES Russian patent published in 2015 - IPC C07D401/14 C07D471/04 A61K31/44 A61K31/4375 A61P27/02 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to compounds of formula

,

wherein pyridine rings A, B and C are independently unsubstituted or substituted by one or more substitutes independently specified in a group consisting of: C_1-6-alkyl, halogen alkyl having 1-6 carbon atoms, Hal or OR¹³; L¹ and L² are independently specified in residues having formula or , wherein at least one of L¹ or L² has formula (b); R¹ and R² are independently specified in a group consisting of hydrogen, C_1-6-alkyl and phenyl; R³ is specified in hydrogen and C_1-6-alkyl; R⁴, R⁵, R⁶ and R⁷ are independently specified in a group consisting of hydrogen and C_1-6-alkyl; R⁸, R⁹, R¹⁰ and R¹¹ are independently specified in a group consisting of hydrogen and C_1-6-alkyl; R¹² is specified in a group consisting of hydrogen and C_1-6-alkyl; R¹³ is independently specified in a group consisting of hydrogen, C_1-6-alkyl and phenyl; p is equal to 1 or 2; q is equal to 0, 1 or 2, and Hal is specified in a group consisting of F, Cl, Br, and I, which can be used in treating a group of amyloid protein related disturbances and disorders.

EFFECT: preparing the compounds which can be used in treating a group of amyloid protein related disturbances and disorders.

17 cl, 1 dwg, 6 tbl, 13 ex